
The new site will expand research capabilities across immunology, neuroscience and oncology

The use of Rinvoq in non-segmental vitiligo is under regulatory review by the US FDA

NSV is a chronic autoimmune disease where the immune system attacks melanin-producing cells, leading to a loss of pigment

Rinvoq is the first and only systemic medication approved in the EU for NSV

Litfulo delivered significant, clinically meaningful improvements for both face and body

The acquisition includes clinical-stage candidates for atopic dermatitis and asthma

Cases of measles have been rising in Europe since 2023

Spanning four dimensions of skin health, the framework introduces 15 terms and definitions

The pharma company has also pledged a $100bn investment in US infrastructure over the next decade

Marketing authorisation follows positive late-stage trial results

Follicular lymphoma affects around 15,000 people in the US every year

Around 700,000 people in the US are living with some form of the autoimmune disease